Waldenström Makroglobulinemisinde Rituksimab İçermeyen Yeni Umut Verici Oral Iksazomib Tedavisi
Wanlu Ma1, JiaWei Zhao2, Lu Zhang31Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Endocrinology, Beijing, China2Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Rheumatology, Beijing, China
3Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Beijing, China
Anahtar Kelimeler: Waldenström makroglobülinemisi, Rituksimab ile indüklenen trombositopeni, Iksazomib
A Promising New Therapy of Oral Ixazomib Without Rituximab for Waldenstrom Macroglobulinemia
Wanlu Ma1, JiaWei Zhao2, Lu Zhang31Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Endocrinology, Beijing, China2Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Rheumatology, Beijing, China
3Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Beijing, China
Keywords: Waldenstrom macroglobulinemia, Rituximabinduced thrombocytopenia, Ixazomib
Wanlu Ma, JiaWei Zhao, Lu Zhang. A Promising New Therapy of Oral Ixazomib Without Rituximab for Waldenstrom Macroglobulinemia. . 2021; 38(1): 87-89
Sorumlu Yazar: Lu Zhang, China
Sorumlu Yazar: Lu Zhang, China
| ARAÇLAR |
 Tam Metin PDF Yazdır Alıntıyı İndir RIS EndNote BibTex Medlars Procite Reference Manager E-Postala Paylaş Yazara e-posta gönder
Benzer makaleler Google Scholar |